The role of mast cells in non-allergic inflammation

Israel Medical Association Journal

Volumn 10, Issue 12, 2008, Pages 843-845

  Weissler, Adaya ^a   Mekori, Yoseph A ^a,b,c   Mor, Adam ^a,b  

^a Department of Pediatrics   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Allergy; Infection; Inflammation; Mast cells

Indexed keywords

CARBOXYPEPTIDASE A; CYTOKINE; ENDOTHELIN 1; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; BEE STING; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MAST CELL; NONHUMAN; SNAKEBITE; ANIMAL; BITES AND STINGS; IMMUNOLOGY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHYSIOLOGY; REVIEW;

ANIMALS; BITES AND STINGS; HUMANS; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELLS;

EID: 59449104264     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Metz M, Maurer M. Mast cells - key effector cells in immune responses. Trends Immunol 2007;28:234-41.
2. Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in allergy. Immunol Allergy Clin North Am 2006;26:407-25.
3. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev 2000;173:131-40.
4. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol 2007;19:31-8.
5. Stelekati E, Orinska Z, Bulfone-Paus S. Mast cells in allergy: innate instructors of adaptive responses. J Imbio 2007;212:505-19.
6. Marshall JS. Mast cell responses to pathogens. Nat Rev Immunol 2004;4:787-99.
7. Dermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 2003;100: 7761-6.
8. Onah DN, Nawa Y. Mucosal mast cell derived chondroitin sulphate levels in and worm expulsion from FcRγ-knockout mice following oral challenge with Strongyloides venezuelensis. J Vet Sci 2004; 5:221-6.
9. Henderson WR, Chi EY. The importance of leukotrienes in mast cell mediated Toxoplasma gondii cytotoxicity. J Infect Dis 1997;177: 1437-43.
10. Ben-Rashed M, Ingram GA, Pentreath VW. Mast cells, histamine and the pathogenesis of intestinal damage in experimental Trypanosoma brucei infections. Ann Trop Med Parasitol 2003;97:803-9.
11. Birdi M, Vouldoukis I, Mossalayi MD, et al. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol 1997;19:475-83.
12. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381:75-7.
13. Malaviva R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
14. Kulka M, Fukuishi N, Rottem M, Mekori YA, Metcalfe DD. Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to FcṘI-mediated activation. J Leukoc Biol 2006;79:339-50.
15. Thankavel K, Madison B, Ikeda T, et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest 1997;100:1123-36.
16. Xu X, Zhang D, Lyubynska N, et al. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 2007;173:219-25.
17. Malaviya R, Ikeda T, Abraham SN. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol Lett 2004; 91:103-11.
18. Genovese A, Borgia G, Bouvet JP, et al. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. Int Arch Allergy Immunol 2003;132:336-45.
19. Abraham S, Shin J, Malaviya R. Type 1 fimbriated Escherichia coli-mast cell interactions in cystitis. J Infect Dis 2001;183(S1):51-5.
20. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 2000;74:7146-50.
21. King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol 2002; 76:8408-19.
22. Brown MA, King CA, Marshall JS, Anderson RP. A dominant role for Fcγ.RII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol 2006;80: 1242-50.
23. Heib V, Becker M, Warger T, et al. Mast cells are crucial for early inflammation, migration of Langerhans cells and CTL responses following topical application of TLR7 ligand in mice. Blood 2007; 110:946-53.
24. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004;114: 174-82.
25. Orinska Z, Bulanova E, Budagian V, Metz M, Maurer M, Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 2005;106:978-87.
26. Sayed BA, Brown MA. Mast cells as modulators of T-cell responses. Immunol Rev 2007;217:53-64.
27. Malaviya R, Twesten N, Ross E, Abraham SN. Mast cells process bacterial antigens through a phagocytic route for class I MHC presentation to T cells. J Immunol 1996;156:1490-6.
28. Warbrick EV, Taylor AM, Botchkarev VA, Coleman JW. Rat connective tissue-type mast cells express MHC class II: up-regulation by IFN-gamma. Cell Immunol 1995;163:222-8.
29. Jawdat DM, Rowden G, Marshall JS. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of langerhans cells in response to bacterial peptidoglycan. J Immunol 2006;177:1755-62.
30. Wang HW, Tedla N, Lloyd AR, Wakefield D, Neil PH. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998;102:1617-26.
31. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007;217:304-28.
32. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-42.
33. Demeure CE, Brahimi K, Hacini F, et al. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol 2005;174: 3932-40.
34. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005;23: 749-86.
35. Weber S, Babina M, Feller G, Henz BM. Human leukaemic mast cells (HMCS-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMCS-1 cells. Scand J Immunol 1997;45:471-81.
36. Stahl JL, Cook EB, Graziano FM, Barney NP. Human conjunctival mast cells: expression of Fc epsilonRI, c-kit, ICAM-1, and IgE. Arch Ophthalmol 1999;117:493-7.
37. Maurer M, Wedemeyer J, Metz M, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004; 432:512-16.
38. Metz M, Piliponsky AM, Chen CC, et al. Mast cells enhance resistance to snake and honeybee venoms. Science 2006;313:526-30.
39. Rivera J. Snake bites and bee stings: the mast cell strikes back. Nature Med 2006;12:999-1000.
40. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nature Rev Allergy Immunol 2007;7:93-104.